Etudes de la conception et des différentes propriétés d’un nouveau revêtement bioactif de stents endovasculaires à base de poly(acide [R,S]-3,3-diméthylmalique) (PDMMLA)

Autor: Gholizadeh Ansari, Elnaz

Publikováno v: Génie chimique. Université Paris-Nord-Paris XIII, 2021. Français. ⟨NNT : 2021PA131022⟩

Atherosclerosis, one of the frequent cardiovascular diseases, is treated by placing a metal stent inthe blocked artery. However, an intra-stent restenosis is observed in 20 to 30% of patients.The objective of this thesis is to develop a new bioactive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::19764815075a2ba4b1ad09c111cfad27
https://tel.archives-ouvertes.fr/tel-03506298

Incidence of major adverse cardiac events in men wishing to continue competitive sport following percutaneous coronary intervention

Autor: Jean Claude Verdier, Gaelle Kervio, Jean Michel Guy, François Carré, Mathew G Wilson, Laurent Chevalier, Sonia Corone, Stéphane Doutreleau, Frédéric Schnell

Publikováno v: Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112 (4), pp.226-233. ⟨10.1016/j.acvd.2018.11.008⟩
Archives of cardiovascular diseases, 2019, 112 (4), pp.226-233. ⟨10.1016/j.acvd.2018.11.008⟩

Summary Background The new North American guidelines for participation in competitive sport in patients with coronary artery disease (CAD) are less restrictive than previous guidelines. Aim To evaluate the incidence of major adverse cardiac events (M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b933d6353d7fb1334ce2010b1e8778d
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01998539

Polymeric films for innovative stent development

Autor: Pallotta, Arnaud

Publikováno v: Médecine humaine et pathologie. Université de Lorraine, 2017. Français. ⟨NNT : 2017LORR0192⟩

Emergency management of ischemic pathologies is initially based on thrombolysis and / or angioplasty and secondly on hygiene-dietetic measures. Angioplasty consists of the destruction of the obstacle located in the artery and is often followed (in 70

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______212::efb049126cf9964d2538d27c138b0c97
https://hal.univ-lorraine.fr/tel-01905755/file/DDOC_T_2017_0192_PALLOTTA.pdf

Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis

Autor: Lijia Ma, Ik-Kyung Jang, Haibo Jia, Jingbo Hou, Junying Kong, Huimin Liu, Lei Xing, Bo Yu, Shaosong Zhang

Publikováno v: Archives of Cardiovascular Diseases. 106(2):79-85

Summary Background The optimal therapy for in-stent restenosis (ISR) is controversial. We evaluated three different strategies for the treatment of in-stent restenosis: cutting balloon angioplasty (CBA), paclitaxel-eluting balloon angioplasty (PEBA)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31fc3f3d5ee0f0694a2842da67632780

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: Comparison between drug-eluting stents and bare-metal stents

Autor: William O. Suddath, Axel de Labriolle, Probal Roy, Laurent Bonello, Lowell F. Satler, Kenneth M. Kent, Daniel H. Steinberg, Kimberly Kaneshige, Gilles Lemesle, Ron Waksman, Joseph Lindsay, Augusto D. Pichard, Zhenyi Xue

Publikováno v: Archives of Cardiovascular Diseases. 102:209-217

SummaryBackgroundIn-stent restenosis remains the major limitation of percutaneous coronary intervention (PCI), particularly after bare-metal stent (BMS) implantation. Drug-eluting stents (DES) decrease in-stent restenosis, which is thought to have mi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1341ca5828c8392bb9e2e85dfd5c5292
https://doi.org/10.1016/j.acvd.2009.01.004